Doctor profile · Federal record
Dr. OLOLADE ADEKOYA, DNP, PMHNP
Psychiatric/Mental Health Nurse Practitioner (CMS: NURSE PRACTITIONER) · Family Nurse Practitioner · Psychiatric/Mental Health Nurse Practitioner · GLEN BURNIE, MD
- NPI 1144686569
- Accepts Medicare
- 8 yrs in practice
- Licensed in 2 states
- Female
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
7845 OAKWOOD RD STE 205
GLEN BURNIE, MD 210614257
(240) 223-0633
Credentials & registration
- NPI registered
- January 2016 — 10 yrs on file
- Profile last updated
- February 14, 2025
- Year of graduation
- 2018 — 8 yrs since
- Specialty taxonomy
- 363LP0808X — NUCC code
- State licenses (2)
- Maryland #R200359 · Virginia #0024176595
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1144686569. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
158
Distinct HCPCS
3
Medicare allowed
$18,998
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 127 | 21 | $114 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 19 | 19 | $197 | |
90833 |
Psychotherapy with evaluation and management visit, 30 minutes | 12 | 11 | $61 |
In context: peer comparison
Among 5 peers in this city , average services per provider: 121. This provider delivers 1.3× the peer median.Open Payments
Industry payments received
All-time total
$2,056
Transactions
57
Manufacturers
13
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 7 | $323.67 | |
| Lundbeck LLC | 8 | $314.65 | |
| Otsuka America Pharmaceutical, Inc. | 4 | $293.26 | |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $286.85 | |
| Indivior Inc. | 16 | $200.30 | |
| Axsome Therapeutics, Inc. | 5 | $184.17 | |
| Neurocrine Biosciences, Inc. | 2 | $162.14 | |
| Janssen Pharmaceuticals, Inc | 1 | $139.97 | |
| Corium, LLC | 3 | $68.84 | |
| Teva Pharmaceuticals USA, Inc. | 1 | $28.88 | |
| Neos Therapeutics, LP | 1 | $22.14 | |
| Orexo US, Inc. | 1 | $15.48 | |
| Alkermes, Inc. | 1 | $15.38 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
124
Patients
0
Total drug cost
$2,072
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Lamotrigine | Generic | 34 | 0 | $215 |
| Quetiapine Fumarate | Generic | 27 | 0 | $339 |
| Dextroamphetamine-Amphetamine (Dextroamphetamine/Amphetamine) | Brand | 14 | 0 | $559 |
| Fluoxetine Hcl | Generic | 14 | 0 | $85 |
| Buspirone Hcl | Generic | 13 | 0 | $112 |
| Alprazolam | Generic | 11 | 0 | $21 |
| Atomoxetine Hcl | Generic | 11 | 0 | $742 |